The Effect on Prognosis of Postoperative CA 19-9 Level in Patients With Pancreatic Cancer

被引：1
作者：
Kilickap, Saadettin [1 ]
Arslan, Cagatay [1 ]
机构：
[1] Hacettepe Univ, Inst Oncol, Dept Med Oncol, Ankara, Turkey
来源：
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2010年 / 33卷 / 03期
关键词：
RECURRENCE; ADENOCARCINOMA; SURVIVAL;
D O I：
10.1097/COC.0b013e31819fe1ff
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：320 / 320
页数：1
相关论文
共 6 条
[1]   Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma [J].
Fujioka, Shuichi ;
Misawa, Takeyuki ;
Okamoto, Tomoyoshi ;
Gocho, Takeshi ;
Futagawa, Yasuro ;
Ishida, Yuichi ;
Yanaga, Katsuhiko .
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 2007, 14 (06) :539-544
[2]   EVALUATION OF THE UTILITY OF A RADIOIMMUNOASSAY FOR SERUM CA-19-9 LEVELS IN PATIENTS BEFORE AND AFTER TREATMENT OF CARCINOMA OF THE PANCREAS [J].
GLENN, J ;
STEINBERG, WM ;
KURTZMAN, SH ;
STEINBERG, SM ;
SINDELAR, WF .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (03) :462-468
[3]   The use of adjusted preoperative CA 19-9 to predict the recurrence of resectable pancreatic cancer [J].
Kang, Chang Moo ;
Kim, Jun Young ;
Choi, Gi Hong ;
Kim, Kyung Sik ;
Choi, Jin Sub ;
Lee, Woo Jung ;
Kim, Byong Ro .
JOURNAL OF SURGICAL RESEARCH, 2007, 140 (01) :31-35
[4]   The Impact of Resection Margin Status and Postoperative CA19-9 Levels on Survival and Patterns of Recurrence After Postoperative High-Dose Radiotherapy With 5-FU-Based Concurrent Chemotherapy for Resectable Pancreatic Cancer [J].
Kinsella, Timothy J. ;
Seo, Yuji ;
Willis, Joseph ;
Stellato, Thomas A. ;
Siegel, Christopher T. ;
Harpp, Deborah ;
Willson, James K. ;
Gibbons, Joseph ;
Sanabria, Juan R. ;
Hardacre, Jeffrey M. ;
Schulak, James P. .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (05) :446-453
[5]  
Leech N.L., 2005, SPSS INTERMEDIATE ST, VSecond, P109
[6]   Prediction of recurrence and survival by post-resection CA 19-9 values in patients with adenocarcinoma of the pancreas [J].
Montgomery, RC ;
Hoffman, JP ;
Riley, LB ;
Rogatko, A ;
Ridge, JA ;
Eisenberg, BL .
ANNALS OF SURGICAL ONCOLOGY, 1997, 4 (07) :551-556
1